Fresenius Medical Care
* For banks, enterprise value is substituted with market cap. Source: Bloomberg Finance L.P.
Fresenius Medical Care appears in the following brand league tables:
Rank 293 in the
Global 500 2013.
Rank 21 in the Germany 50 2013.
Rank 269 in the Global 500 2012.
Rank 21 in the Germany 30 2012.
Rank 261 in the Global 500 2011.
Rank 20 in the Germany 30 2011.
Rank 292 in the Global 500 2010.
2013 brand performance*
* Figures taken on 31st December 2012.
2012 brand performance*
* Figures taken on 31st December 2011.
2011 brand performance*
* Figures taken on 31st December 2010.
2010 brand performance*
* Figures taken on 31st December 2009.
"Creating a future worth living. For people. Worldwide. Every day."
Although Fresenius Medical Care AG was only founded in 1996, its history dates back to the 18th century. In 1462, the first Hirsch-pharmacy was established in Frankfurt am Main, Germany, which, in the 18th century, came under the ownership of the Fresenius family. Dr. Eduard Fresenius himself started with the production of pharmaceuticals in 1912, followed by the establishment of a separate production plant in Bad Homburg. In the 1970s, Fresenius started to expand its business into the dialysis segment, primarily focusing on the production of dialysers. In 1996, finally, Fresenius Medical Care had its IPO at the Frankfurt and New York Stock Exchange and was officially founded. During the early 2000s, the company soon became one of the market leaders within the dialysis business, serving more than 120,000 patients all over the globe. In March 2006, Fresenius acquired the Renal Care Group, Inc., developing and operating dialysis centres across the United States. This acquisition further fostered Fresenius’ position as market leader, resulting in the production of 500 million dialysers in 2007. Until today, Fresenius Medical Care AG has been providing over 30 million dialysis treatment to more than 200,000 patients worldwide.